ArticleFrontiers of optoelectronics2021
Improved stability of blue TADF organic electroluminescent diodes via OXD-7 based mixed host.
Article in Frontiers of optoelectronics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blue emitting exciplex for yellow and white organic light-emitting diodes.Frontiers of optoelectronics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thermally activated delayed fluorescence (TADF) organic light-emitting diodes (OLEDs) have been demonstrated in applications such as displays and solid-state lightings. However, weak stability and inefficient emission of blue TADF OLEDs are two key bottlenecks limiting the development of solution processable displays and white light sources. This work presents a solution-processed OLED using a blue-emitting TADF small molecule bis[4-(9,9-dimethyl-9,10-dihydroacridine) phenyl]sulfone (DMAC-DPS) as an emitter. We comparatively investigated the effects of single host poly(N-vinylcarbazole) (PVK) and a co-host of 60% PVK and 30% 2,2'-(1,3-phenylene)-bis[5-(4-tert-butylphenyl)-1,3,4-oxadiazole] (OXD-7) on the device performance (the last 10% is emitter DMAC-DPS). The co-host device shows lower turn-on voltage, similar maximum luminance, and much slower external quantum efficiency (EQE) rolloff. In other words, device stability improved by doping OXD-7 into PVK, and the device impedance simultaneously and significantly reduced from 8.6 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.